The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to ficerafusp alfa together with Keytruda (pembrolizumab) for the primary...
The U.S. Meals and Drug Administration (FDA) has accredited Inluriyo (imlunestrant) for the therapy of adults with estrogen receptor (ER)-positive and HER2-negative...
